Micropaque Ct

Barium sulfate, the active ingredient in Micropaque Ct, is a contrast agent presented as a suspension for oral and rectal use. It provides radiopaque contrast for imaging of the gastrointestinal tract and is employed in diagnostic radiology procedures. GNH USA supplies Micropaque Ct as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque Ct is a barium‑based contrast medium used in gastrointestinal radiographic examinations. - Esophageal barium study: delineates the esophageal lumen and detects strictures or motility disorders. - Stomach barium study: outlines gastric anatomy and identifies ulcers, masses, or anatomical anomalies. - Small‑intestine barium study: visualises mucosal patterns and detects malabsorption or inflammatory disease. - Colon barium study: highlights colonic contour and assists in detecting polyps, diverticula, or inflammatory changes.

Adverse reactions may occur following administration of Micropaque Ct.

Common Side Effects: - Nausea: mild to moderate feeling of queasiness. - Abdominal cramping: transient discomfort in the stomach or intestines. - Constipation: reduced bowel movements after the study. - Taste disturbance: metallic or chalky sensation in the mouth.

Serious or Rare Side Effects: - Allergic reaction or anaphylaxis: hives, swelling, difficulty breathing. - Aspiration pneumonitis: lung inflammation if barium is inhaled. - Bowel obstruction or perforation: especially in patients with pre‑existing strictures. - Severe electrolyte imbalance: due to large-volume administration. - Persistent severe constipation leading to impaction.

Prior to using Micropaque Ct, clinicians should consider several safety measures. - Assess gastrointestinal patency: confirm no suspected obstruction before administration. - Avoid use in patients with known hypersensitivity to barium sulfate. - Consider alternative contrast agents for patients with severe constipation. - Monitor for signs of aspiration in individuals with dysphagia or impaired swallowing. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Barium sulfate has limited pharmacokinetic interactions, but certain co‑administered agents may require attention.

Major Interactions (Avoid): - Lithium therapy: dehydration from bowel preparation may alter lithium levels. - Anticoagulants (e.g., warfarin): large‑volume barium studies can increase risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may affect suspension consistency. - Diuretics: monitor fluid balance when large volumes of barium are given. - Prokinetic agents: may change transit time of the contrast medium.